A Propensity-Score Matched Analysis to Evaluate Local Treatment Modalities for Esophageal Squamous Cell Carcinoma in Over 80 years on A SEER Database

In conclusion, CDS was the preferred treatment for esophageal squamous cell cancer patients with 80-84 years older, and there was no difference between CDS and RT for patients with≥85 years older. This study highlight the value of different local treatments for esophageal squamous cell carcinoma over 80 years patients, especially for ≥85 years older. Further studies are needed to understand drivers of this bias and enhance equality in old patient treatment.